Progesterone to prevent spontaneous preterm birth

Seminars in Fetal and Neonatal Medicine

Volumn 19, Issue 1, 2014, Pages 15-26

  Romero, Roberto ^a,b,c   Yeo, Lami ^a,d   Chaemsaithong, Piya ^a,d   Chaiworapongsa, Tinnakorn ^a,d   Hassan, Sonia S ^a,d  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

^d WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cervical cerclage; Cervical length; Cervical ultrasound; Short cervix; Ultrasound; Vaginal progesterone

Indexed keywords

HYDROXYPROGESTERONE CAPROATE; PROGESTERONE;

COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; ECHOGRAPHY; GESTATIONAL AGE; HUMAN; MEDICAL HISTORY; PREGNANCY; PREMATURE LABOR; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; TWIN PREGNANCY; UTERINE CERVIX CERCLAGE;

CERVICAL CERCLAGE; CERVICAL LENGTH; CERVICAL ULTRASOUND; SHORT CERVIX; ULTRASOUND; VAGINAL PROGESTERONE;

ADMINISTRATION, INTRAVAGINAL; CERVIX UTERI; FEMALE; HUMANS; INFANT, NEWBORN; PREGNANCY; PREMATURE BIRTH; PROGESTERONE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84891662927     PISSN: 1744165X     EISSN: 18780946     Source Type: Journal    
DOI: 10.1016/j.siny.2013.10.004     Document Type: Review

References (129)

1. Blencowe H., Cousens S., Oestergaard M.Z., Chou D., Moller A.B., Narwal R., et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet 2012, 379:2162-2172.
2. Beck S., Wojdyla D., Say L., Betran A.P., Merialdi M., Requejo J.H., et al. The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity. Bull WHO 2010, 88:31-38.
3. Romero R. Vaginal progesterone to reduce the rate of preterm birth and neonatal morbidity: a solution at last. Women's Health 2011, 7:501-504.
4. Liu L., Johnson H.L., Cousens S., Perin J., Scott S., Lawn J.E., et al. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet 2012, 379:2151-2161.
5. Jongbloed-Pereboom M., Janssen A.J., Steenbergen B., Nijhuis-Van Der Sanden M.W. Motor learning and working memory in children born preterm: a systematic review. Neurosci Biobehav Rev 2012, 36:1314-1330.
6. Mwaniki M.K., Atieno M., Lawn J.E., Newton C.R. Long-term neurodevelopmental outcomes after intrauterine and neonatal insults: a systematic review. Lancet 2012, 379:445-452.
7. Gravett M.G., Rubens C.E. Aframework for strategic investments in research to reduce the global burden of preterm birth. Am J Obstet Gynecol 2012, 207:368-373.
8. Grobman W.A. Making sense of preterm birth. Am J Obstet Gynecol 2012, 206:99-100.
9. Taylor H.G. Outcomes of late preterm birth: who is at risk and for what?. Am J Obstet Gynecol 2012, 206:181-182.
10. Bastek J.A., Sammel M.D., Pare E., Srinivas S.K., Posencheg M.A., Elovitz M.A. Adverse neonatal outcomes: examining the risks between preterm, late preterm, and term infants. Am J Obstet Gynecol 2008, 199:367.e1-367.e8.
11. McCormick M.C., Litt J.S., Smith V.C., Zupancic J.A. Prematurity: an overview and public health implications. Annu Rev Public Health 2011, 32:367-379.
12. Romero R., Sirtori M., Oyarzun E., Avila C., Mazor M., Callahan R., et al. Infection and labor. V. Prevalence, microbiology, and clinical significance of intraamniotic infection in women with preterm labor and intact membranes. Am J Obstet Gynecol 1989, 161:817-824.
13. Yoon B.H., Romero R., Yang S.H., Jun J.K., Kim I.O., Choi J.H., et al. Interleukin-6 concentrations in umbilical cord plasma are elevated in neonates with white matter lesions associated with periventricular leukomalacia. Am J Obstet Gynecol 1996, 174:1433-1440.
14. Yoon B.H., Jun J.K., Romero R., Park K.H., Gomez R., Choi J.H., et al. Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1beta, and tumor necrosis factor-alpha), neonatal brain white matter lesions, and cerebral palsy. Am J Obstet Gynecol 1997, 177:19-26.
15. Yoon B.H., Romero R., Park J.S., Kim C.J., Kim S.H., Choi J.H., et al. Fetal exposure to an intra-amniotic inflammation and the development of cerebral palsy at the age of three years. Am J Obstet Gynecol 2000, 182:675-681.
16. Yoon B.H., Romero R., Moon J.B., Shim S.S., Kim M., Kim G., et al. Clinical significance of intra-amniotic inflammation in patients with preterm labor and intact membranes. Am J Obstet Gynecol 2001, 185:1130-1136.
17. Romero R., Gotsch F., Pineles B., Kusanovic J.P. Inflammation in pregnancy: its roles in reproductive physiology, obstetrical complications, and fetal injury. Nutr Rev 2007, 65:S194-S202.
18. Dessardo N.S., Mustac E., Dessardo S., Banac S., Peter B., Finderle A., et al. Chorioamnionitis and chronic lung disease of prematurity: a path analysis of causality. Am J Perinatol 2012, 29:133-140.
19. Sato M., Nishimaki S., Yokota S., Seki K., Horiguchi H., An H., et al. Severity of chorioamnionitis and neonatal outcome. JObstet Gynaecol Res 2011, 37:1313-1319.
20. Gantert M., Been J.V., Gavilanes A.W., Garnier Y., Zimmermann L.J., Kramer B.W. Chorioamnionitis: a multiorgan disease of the fetus?. JPerinatol 2010, 30(Suppl.):S21-S30.
21. Romero R., Espinoza J., Kusanovic J.P., Gotsch F., Hassan S., Erez O., et al. The preterm parturition syndrome. Br J Obstet Gynecol 2006, 113(Suppl.3):17-42.
22. Romero R. Prenatal medicine: the child is the father of the man. Prenatal Neonatal Med 1996, 1:8-11.
23. Romero R. Prenatal medicine: the child is the father of the man. JMaternal-Fetal Neonatal Med 1996, 2009(22):636-639.
24. Romero R., Gomez R., Mazor M., Ghezzi F., Yoon B.H. The preterm labor syndrome. Preterm labor 1997, 29-49. Churchill Livingstone, New York. M. Elder, R. Romero, R. Lamont (Eds.).
25. Romero R., Yeo L., Miranda J., Hassan S.S., Conde-Agudelo A., Chaiworapongsa T. Ablueprint for the prevention of preterm birth: vaginal progesterone in women with a short cervix. JPerinat Med 2013, 41:27-44.
26. Romero R., Mazor M., Munoz H., Gomez R., Galasso M., Sherer D.M. The preterm labor syndrome. Ann NY Acad Sci 1994, 734:414-429.
27. Romero R., Chaiworapongsa T., Gotsch F., Yeo L., Madan I., Hassan S.S. The diagnosis and management of preterm labor with intact membranes. Clinical maternal-fetal medicine online 2011, Informa Healthcare, London. 2nd ed. H.N. Winn, F.A. Chervenak, R. Romero (Eds.).
28. Iams J.D., Johnson F.F., Sonek J., Sachs L., Gebauer C., Samuels P. Cervical competence as a continuum: a study of ultrasonographic cervical length and obstetric performance. Am J Obstet Gynecol 1995, 172:1097-1103.
29. Althuisius S., Dekker G., Hummel P., Bekedam D., Kuik D., Van Geijn H. Cervical Incompetence Prevention Randomized Cerclage Trial (CIPRACT): effect of therapeutic cerclage with bed rest vs bed rest only on cervical length. Ultrasound Obstet Gynecol 2002, 20:163-167.
30. Romero R., Espinoza J., Erez O., Hassan S. The role of cervical cerclage in obstetric practice: can the patient who could benefit from this procedure be identified?. Am J Obstet Gynecol 2006, 194:1-9.
31. Berghella V. Cerclage decreases preterm birth: finally the level I evidence is here. Am J Obstet Gynecol 2011, 205:89-90.
32. Romero R., Espinoza J., Mazor M., Chaiworapongsa T. The preterm parturition syndrome. Preterm Birth 2004, RCOG Press, London. H. Critchely, P. Bennett, S. Thornton (Eds.).
33. Csapo A.I., Knobil E., Van Der Molen H.J., Wiest W.G. Peripheral plasma progesterone levels during human pregnancy and labor. Am J Obstet Gynecol 1971, 110:630-632.
34. Csapo A.I., Pulkkinen M.O., Ruttner B., Sauvage J.P., Wiest W.G. The significance of the human corpus luteum in pregnancy maintenance. I. Preliminary studies. Am J Obstet Gynecol 1972, 112:1061-1067.
35. Csapo A.I., Pulkkinen M.O., Kaihola H.L. The effect of luteectomy-induced progesterone-withdrawal on the oxytocin and prostaglandin response of the first trimester pregnant human uterus. Prostaglandins 1973, 4:421-429.
36. Csapo A.I., Erdos T. The critical control of progesterone levels and pregnancy by antiprogesterone. Am J Obstet Gynecol 1976, 126:598-601.
37. Csapo A.I., Erdos T. Prevention of the abortifacient action of antiprogesterone serum by progesterone. Am J Obstet Gynecol 1977, 128:212-214.
38. Kerenyi T. Forgotten "father of progesterone". Am J Obstet Gynecol 2010, 202:e10-e11.
39. Romero R., Stanczyk F.Z. Progesterone is not the same as 17alpha-hydroxyprogesterone caproate: implications for obstetrical practice. Am J Obstet Gynecol 2013, 208:421-426.
40. Murthy Y.S., Arronet G.H., Parekh M.C. Luteal phase inadequacy. Its significance in infertility. Obstet Gynecol 1970, 36:758-761.
41. Stites D.P., Siiteri P.K. Steroids as immunosuppressants in pregnancy. Immunol Rev 1983, 75:117-138.
42. Fidel P.I., Romero R., Maymon E., Hertelendy F. Bacteria-induced or bacterial product-induced preterm parturition in mice and rabbits is preceded by a significant fall in serum progesterone concentrations. JMatern Fetal Med 1998, 7:222-226.
43. Chwalisz K. The use of progesterone antagonists for cervical ripening and as an adjunct to labour and delivery. Hum Reprod 1994, 9(Suppl.1):131-161.
44. Pepe G.J., Albrecht E.D. Actions of placental and fetal adrenal steroid hormones in primate pregnancy. Endocr Rev 1995, 16:608-648.
45. Henson M.C. Pregnancy maintenance and the regulation of placental progesterone biosynthesis in the baboon. Hum Reprod Update 1998, 4:389-405.
46. Bernal A.L. Overview of current research in parturition. Exp Physiol 2001, 86:213-222.
47. Young I.R. The comparative physiology of parturition in mammals. The endocrinology of parturition 2001, Reinhardt Druck, Basel. R. Smith (Ed.).
48. Mesiano S. Roles of estrogen and progesterone in human parturition. Front Horm Res 2001, 27:86-104.
49. Mesiano S. Myometrial progesterone responsiveness and the control of human parturition. JSoc Gynecol Invest 2004, 11:193-202.
50. Lye S.J. The initiation and inhibition of labor: towards a molecular understanding. Semin Reprod Endocrinol 1994, 12:284-294.
51. Stjernholm Y., Sahlin L., Akerberg S., Elinder A., Eriksson H.A., Malmström A., et al. Cervical ripening in humans: potential roles of estrogen, progesterone, and insulin-like growth factor-I. Am J Obstet Gynecol 1996, 174:1065-1071.
52. Lye S.J., Ou C.W., Tech T.G., Erb G., Stevens Y., Casper R., et al. The molecular basis of labour and tocolysis. Fetal Maternal Med Rev 1998, 10:121-136.
53. Smith R., Mesiano S., Mcgrath S. Hormone trajectories leading to human birth. Regul Pept 2002, 108:159-164.
54. Oh S.Y., Kim C.J., Park I., Romero R., Sohn Y.K., Moon K.C., et al. Progesterone receptor isoform (A/B) ratio of human fetal membranes increases during term parturition. Am J Obstet Gynecol 2005, 193:1156-1160.
55. Smith R. Parturition. NEngl J Med 2007, 356:271-283.
56. Chwalisz K., Shi Shao O., Neff G., Elger J. The effect of antigestagen ZK 98, 199 on the uterine cervix. Acta Endocrinol 1987, 283:113.
57. Norman J. Antiprogesterones. Br J Hosp Med 1991, 45:372-375.
58. Elliott C.L., Brennand J.E., Calder A.A. The effects of mifepristone on cervical ripening and labor induction in primigravidae. Obstet Gynecol 1998, 92:804-809.
59. Stenlund P.M., Ekman G., Aedo A.R., Bygdeman M. Induction of labor with mifepristone - a randomized, double-blind study versus placebo. Acta Obstet Gynecol Scand 1999, 78:793-798.
60. Giacalone P.L., Daures J.P., Faure J.M., Boulot P., Hedon B., Laffargue F. The effects of mifepristone on uterine sensitivity to oxytocin and on fetal heart rate patterns. Eur J Obstet Gynecol Reprod Biol 2001, 97:30-34.
61. Word R.A., Li X.H., Hnat M., Carrick K. Dynamics of cervical remodeling during pregnancy and parturition: mechanisms and current concepts. Semin Reprod Med 2007, 25:69-79.
62. Iams J.D., Goldenberg R.L., Meis P.J., Mercer B.M., Moawad A., Das A., et al. The length of the cervix and the risk of spontaneous premature delivery. National Institute of Child Health and Human Development Maternal Fetal Medicine Unit Network. NEngl J Med 1996, 334:567-572.
63. Berghella V., Kuhlman K., Weiner S., Texeira L., Wapner R.J. Cervical funneling: sonographic criteria predictive of preterm delivery. Ultrasound Obstet Gynecol 1997, 10:161-166.
64. Heath V.C., Southall T.R., Souka A.P., Elisseou A., Nicolaides K.H. Cervical length at 23 weeks of gestation: prediction of spontaneous preterm delivery. Ultrasound Obstet Gynecol 1998, 12:312-317.
65. Taipale P., Hiilesmaa V. Sonographic measurement of uterine cervix at 18-22 weeks' gestation and the risk of preterm delivery. Obstet Gynecol 1998, 92:902-907.
66. Hassan S.S., Romero R., Berry S.M., Dang K., Blackwell S.C., Treadwell M.C., et al. Patients with an ultrasonographic cervical length < or= 15mm have nearly a 50% risk of early spontaneous preterm delivery. Am J Obstet Gynecol 2000, 182:1458-1467.
67. Botsis D., Papagianni V., Vitoratos N., Makrakis E., Aravantinos L., Creatsas G. Prediction of preterm delivery by sonographic estimation of cervical length. Biol Neonate 2005, 88:42-45.
68. De Carvalho M.H., Bittar R.E., Brizot M.L., Bicudo C., Zugaib M. Prediction of preterm delivery in the second trimester. Obstet Gynecol 2005, 105:532-536.
69. Grimes-Dennis J., Berghella V. Cervical length and prediction of preterm delivery. Curr Opin Obstet Gynecol 2007, 19:191-195.
70. Celik E., To M., Gajewska K., Smith G.C., Nicolaides K.H. Cervical length and obstetric history predict spontaneous preterm birth: development and validation of a model to provide individualized risk assessment. Ultrasound Obstet Gynecol 2008, 31:549-554.
71. Tekesin I., Eberhart L.H., Schaefer V., Wallwiener D., Schmidt S. Evaluation and validation of a new risk score (CLEOPATRA score) to predict the probability of premature delivery for patients with threatened preterm labor. Ultrasound Obstet Gynecol 2005, 26:699-706.
72. Owen J., Yost N., Berghella V., Thom E., Swain M., Dildy G.A., et al. Mid-trimester endovaginal sonography in women at high risk for spontaneous preterm birth. JAMA 2001, 286:1340-1348.
73. To M.S., Skentou C.A., Royston P., Yu C.K., Nicolaides K.H. Prediction of patient-specific risk of early preterm delivery using maternal history and sonographic measurement of cervical length: a population-based prospective study. Ultrasound Obstet Gynecol 2006, 27:362-367.
74. Fonseca E.B., Celik E., Parra M., Singh M., Nicolaides K.H. Progesterone and the risk of preterm birth among women with a short cervix. NEngl J Med 2007, 357:462-469.
75. Hassan S.S., Romero R., Vidyadhari D., Fusey S., Baxter J.K., Khandelwal M., et al. Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol 2011, 38:18-31.
76. Higgins J.P.T., Altman D.G., Sterne J.A.C. Assessing risk of bias in included studies. Cochrane handbook for systematic reviews of interventions version 510 (updated March 2011) 2011, [Chapter 8], Cochrane Collaboration. J.P.T. Higgins, S. Green (Eds.).
77. Stewart L.A., Parmar M.K. Meta-analysis of the literature or of individual patient data: is there a difference?. Lancet 1993, 341:418-422.
78. Romero R., Nicolaides K., Conde-Agudelo A., Tabor A., O'Brien J.M., Cetingoz E., et al. Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient data. Am J Obstet Gynecol 2012, 206. 124.e1-19.
79. O'Brien J.M., Adair C.D., Lewis D.F., Hall D.R., Defranco E.A., Fusey S., et al. Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol 2007, 30:687-696.
80. Cetingoz E., Cam C., Sakalli M., Karateke A., Celik C., Sancak A. Progesterone effects on preterm birth in high-risk pregnancies: a randomized placebo-controlled trial. Arch Gynecol Obstet 2011, 283:423-429.
81. Rode L., Klein K., Nicolaides K., Krampl-Bettelheim E., Tabor A. Prevention of preterm delivery in twin gestations (PREDICT): a multicentre randomised placebo-controlled trial on the effect of vaginal micronised progesterone. Ultrasound Obstet Gynecol 2011, 38:272-280.
82. Stanczyk F.Z. All progestins are not created equal. Steroids 2003, 68:879-890.
83. Role of progestogen in hormone therapy for postmenopausal women: position statement of North American Menopause Society. Menopause 2003, 10:113-132.
84. Schindler A.E., Campagnoli C., Druckmann R., Huber J., Pasqualini J.R., Schweppe K.W., et al. Classification and pharmacology of progestins. Maturitas 2008, 61:171-180.
85. Stanczyk F.Z., Hapgood J.P., Winer S., Mishell D.R. Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects. Endocr Rev 2013, 34:171-208.
86. Romero R. Prevention of spontaneous preterm birth: the role of sonographic cervical length in identifying patients who may benefit from progesterone treatment. Ultrasound Obstet Gynecol 2007, 30:675-686.
87. Grobman W.A., Thom E.A., Spong C.Y., Iams J.D., Saade G.R., Mercer B.M., et al. 17 alpha-hydroxyprogesterone caproate to prevent prematurity in nulliparas with cervical length less than 30mm. Am J Obstet Gynecol 2012, 207:390.e1-390.e8.
88. Durnwald C.P., Lynch C.D., Walker H., Iams J.D. The effect of treatment with 17 alpha-hydroxyprogesterone caproate on changes in cervical length over time. Am J Obstet Gynecol 2009, 201:410.e1-410.e5.
89. Meis P.J., Klebanoff M., Thom E., Dombrowski M.P., Sibai B., Moawad A.H., et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. NEngl J Med 2003, 348:2379-2385.
90. Keirse M.J. Progesterone and preterm: seventy years of "deja vu" or "still to be seen"?. Birth 2004, 31:230-235.
91. Iams J.D., Newman R.B., Thom E.A., Goldenberg R.L., Mueller-Heubach E., Moawad A., et al. Frequency of uterine contractions and the risk of spontaneous preterm delivery. NEngl J Med 2002, 346:250-255.
92. Greene M.F. Progesterone and preterm delivery - deja vu all over again. NEngl J Med 2003, 348:2453-2455.
93. Meis P.J. 17 Hydroxyprogesterone for the prevention of preterm delivery. Obstet Gynecol 2005, 105:1128-1135.
94. American College of Obstetricians and Gynecologists Committee Opinion Number 419 October 2008 (Replaces no.291, November 2003) Use of progesterone to reduce preterm birth. Obstet Gynecol 2008, 112:963-965.
95. Farine D., Mundle W.R., Dodd J., Basso M., Delisle M.F., Farine D., et al. The use of progesterone for prevention of preterm birth. JObstet Gynaecol Can 2008, 30:67-77.
96. 17α-Alpha hydroxyprogesterone caproate for prevention of preterm birth 2006, Food and Drug Administration Review by the Division of Reproductive and Urologic Products, Overview of FDA Background Document.
97. United States Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation and Research (CBER) Guidance for industry: goodpharmacovigilance practices and pharmacoepidemiologic assessment 2005.
98. Combs C.A., Garite T., Maurel K., Das A., Porto M. Failure of 17-hydroxyprogesterone to reduce neonatal morbidity or prolong triplet pregnancy: a double-blind, randomized clinical trial. Am J Obstet Gynecol 2010, 203:248.e1-248.e9.
99. Senat M.V., Porcher R., Winer N., Vayssière C., Deruelle P., Capelle M., et al. Prevention of preterm delivery by 17 alpha-hydroxyprogesterone caproate in asymptomatic twin pregnancies with a short cervix: a randomized controlled trial. Am J Obstet Gynecol 2013, 208. 194.e1-8.
100. Conde-Agudelo A., Romero R., Nicolaides K., Chaiworapongsa T., O'Brien J.M., Cetingoz E., et al. Vaginal progesterone vs cervical cerclage for the prevention of preterm birth in women with a sonographic short cervix, previous preterm birth, and singleton gestation: a systematic review and indirect comparison metaanalysis. Am J Obstet Gynecol 2013, 208:42.e1-42.e18.
101. Norman J.E., Mackenzie F., Owen P., Mactier H., Hanretty K., Cooper S., et al. Progesterone for the prevention of preterm birth in twin pregnancy (STOPPIT): a randomised, double-blind, placebo-controlled study and meta-analysis. Lancet 2009, 373:2034-2040.
102. Wood S., Ross S., Tang S., Miller L., Sauve R., Brant R. Vaginal progesterone to prevent preterm birth in multiple pregnancy: a randomized controlled trial. JPerinat Med 2012 Jul 14, [Epub ahead of print].
103. Serra V., Perales A., Meseguer J., Parrilla J.J., Lara C., Bellver J., et al. Increased doses of vaginal progesterone for the prevention of preterm birth in twin pregnancies: a randomised controlled double-blind multicentre trial. Br J Obstet Gynecol 2013, 120:50-57.
104. Romero R. Progesterone to prevent preterm birth in twin gestations: what is the next step forward?. Br J Obstet Gynecol 2013, 120:1-4.
105. Souka A.P., Heath V., Flint S., Sevastopoulou I., Nicolaides K.H. Cervical length at 23 weeks in twins in predicting spontaneous preterm delivery. Obstet Gynecol 1999, 94:450-454.
106. Conde-Agudelo A., Romero R., Hassan S.S., Yeo L. Transvaginal sonographic cervical length for the prediction of spontaneous preterm birth in twin pregnancies: a systematic review and metaanalysis. Am J Obstet Gynecol 2010, 203. 128.e1-12.
107. Berghella V., Rafael T.J., Szychowski J.M., Rust O.A., Owen J. Cerclage for short cervix on ultrasonography in women with singleton gestations and previous preterm birth: a meta-analysis. Obstet Gynecol 2011, 117:663-671.
108. Althuisius S.M., Dekker G.A., Hummel P., Bekedam D.J., Van Geijn H.P. Final results of the Cervical Incompetence Prevention Randomized Cerclage Trial (CIPRACT): therapeutic cerclage with bed rest versus bed rest alone. Am J Obstet Gynecol 2001, 185:1106-1112.
109. Rust O.A., Atlas R.O., Reed J., Van Gaalen J., Balducci J. Revisiting the short cervix detected by transvaginal ultrasound in the second trimester: why cerclage therapy may not help. Am J Obstet Gynecol 2001, 185:1098-1105.
110. Berghella V., Odibo A.O., Tolosa J.E. Cerclage for prevention of preterm birth in women with a short cervix found on transvaginal ultrasound examination: a randomized trial. Am J Obstet Gynecol 2004, 191:1311-1317.
111. To M.S., Alfirevic Z., Heath V.C., Cicero S., Cacho A.M., Williamson P.R., et al. Cervical cerclage for prevention of preterm delivery in women with short cervix: randomised controlled trial. Lancet 2004, 363:1849-1853.
112. Owen J., Hankins G., Iams J.D., Berghella V., Sheffield J.S., Perez-Delboy A., et al. Multicenter randomized trial of cerclage for preterm birth prevention in high-risk women with shortened midtrimester cervical length. Am J Obstet Gynecol 2009, 201:375.e1-375.e8.
113. Benichou J., Bellissant E., Chastang C. Analysis of phase II clinical trials in haematology and oncology: comparison of the triangular test to the usual methods. Stat Med 1991, 10:989. discussion 89-90.
114. Song F., Altman D.G., Glenny A.M., Deeks J.J. Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses. BMJ Clin Res Ed 2003, 326:472.
115. Edwards S.J., Clarke M.J., Wordsworth S., Borrill J. Indirect comparisons of treatments based on systematic reviews of randomised controlled trials. Int J Clin Pract 2009, 63:841-854.
116. Wells G.A., Sultan A., Chen L., Khan M., Coyle D. Indirect evidence: indirect treatment comparisons in meta-analysis 2009, Canadian Agency for Drugs and Technologies in Health, Ottawa.
117. Hutcheon J.A., Skoll M.A., Eastabrook G.D., Lim K.I. The case for universal cervical length screening to prevent preterm birth: is it strong enough to change practice in Canada?. JObstet Gynaecol Can 2012, 34:1184-1187.
118. Campbell S. Universal cervical-length screening and vaginal progesterone prevents early preterm births, reduces neonatal morbidity and is cost saving: doing nothing is no longer an option. Ultrasound Obstet Gynecol 2011, 38:1-9.
119. Combs C.A. Vaginal progesterone for asymptomatic cervical shortening and the case for universal screening of cervical length. Am J Obstet Gynecol 2012, 206:101-103.
120. Progesterone and preterm birth prevention: translating clinical trials data into clinical practice. Am J Obstet Gynecol 2012, 206:376-386.
121. Lockwood C.J. The real progesterone story. Contemp Obstet Gynecol 2011, 5:10-15.
122. Khandelwal M. Vaginal progesterone in risk reduction of preterm birth in women with short cervix in the midtrimester of pregnancy. Int J Women's Health 2012, 4:481-490.
123. Berghella V. Universal cervical length screening for prediction and prevention of preterm birth. Obstet Gynecol Surv 2012, 67:653-658.
124. Podobnik M., Bulic M., Smiljanic N., Bistricki J. Ultrasonography in the detection of cervical incompetency. JClin Ultrasound 1988, 16:383-391.
125. Hernandez-Andrade E., Romero R., Ahn H., Hussein Y., Yeo L., Korzeniewski S.J., et al. Transabdominal evaluation of uterine cervical length during pregnancy fails to identify a substantial number of women with a short cervix. JMaternal-Fetal Neonatal Med 2012, 25:1682-1689.
126. Parry S., Simhan H., Elovitz M., Iams J. Universal maternal cervical length screening during the second trimester: pros and cons of a strategy to identify women at risk of spontaneous preterm delivery. Am J Obstet Gynecol 2012, 207:101-106.
127. Cahill A.G., Odibo A.O., Caughey A.B., Stamilio D.M., Hassan S.S., Macones G.A., et al. Universal cervical length screening and treatment with vaginal progesterone to prevent preterm birth: a decision and economic analysis. Am J Obstet Gynecol 2010, 202:548.e1-548.e8.
128. Werner E.F., Han C.S., Pettker C.M., Buhimschi C.S., Copel J.A., Funai E.F., et al. Universal cervical-length screening to prevent preterm birth: a cost-effectiveness analysis. Ultrasound Obstet Gynecol 2011, 38:32-37.
129. Page J., Emerson J., Cahill A.G., Allen A., Fowler J., Pereira L., et al. The impact of cervical length on the cost-effectness of vaginal progesterone as a preterm birth intervention. Am J Obstet Gynecol 2013, 208(Suppl.1):S66.